Results 21 to 30 of about 433,923 (290)

Carcinogenesis of Pancreatic Ductal Adenocarcinoma [PDF]

open access: yesGastroenterology, 2020
Although the estimated time for development of pancreatic ductal adenocarcinoma (PDA) is more than 20 years, PDAs are usually detected at late, metastatic stages. PDAs develop from duct-like cells through a multistep carcinogenesis process, from low-grade dysplastic lesions to carcinoma in situ and eventually to metastatic disease.
Peter, Storz, Howard C, Crawford
openaire   +2 more sources

Desmoplasia of Pancreatic Ductal Adenocarcinoma [PDF]

open access: yesClinical Gastroenterology and Hepatology, 2009
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer and is characterized by remarkable desmoplasia. The desmoplasia is composed of extracellular matrix (ECM) proteins, myofibroblastic pancreatic stellate cells, and immune cells associated with a multitude of cytokines, growth factors, and ECM metabolizing enzymes.
Stephen, Pandol   +4 more
openaire   +2 more sources

Familial Pancreatic Ductal Adenocarcinoma [PDF]

open access: yesThe American Journal of Pathology, 2019
Pancreatic ductal adenocarcinoma (PDAC), although a rare disease, has a poor prognosis. With 5-year overall survival of 8%, there is a critical need to detect PDAC early or at a premalignant stage. Current screening methods are largely imaging based, but a more focused screening approach based on modifiable and nonmodifiable risk factors may improve ...
Kelly E, Diaz, Aimee L, Lucas
openaire   +2 more sources

An Immunological Glance on Pancreatic Ductal Adenocarcinoma [PDF]

open access: yesInternational Journal of Molecular Sciences, 2020
Pancreatic ductal adenocarcinoma (PDAC) has still a dismal prognosis. Different factors such as mutational landscape, intra- and intertumoral heterogeneity, stroma, and immune cells impact carcinogenesis of PDAC associated with an immunosuppressive microenvironment. Different cell types with partly opposing roles contribute to this milieu.
Michael Karl Melzer   +7 more
openaire   +2 more sources

Mimics of pancreatic ductal adenocarcinoma [PDF]

open access: yesCancer Imaging, 2013
Several uncommon primary pancreatic tumors, inflammatory conditions, metastasis to the pancreas and peripancreatic masses can mimic the appearance of pancreatic ductal adenocarcinoma (PDA). Differentiation between these lesions and PDA can be challenging, due to the overlap in imaging features; however, familiarity with their typical imaging features ...
Al-Hawary, Mahmoud M.   +4 more
openaire   +2 more sources

Tumour–stroma interactions in an organotypic culture model of pancreatic cancer [PDF]

open access: yes, 2011
PhDPancreatic cancer is characterised by an intense fibrotic, or desmoplastic, stroma, which contributes to tumour progression. Three-dimensional in vitro culture models incorporating this non-tumour component may more closely recapitulate the ...
Froeling, Fieke E.M.
core   +4 more sources

microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells [PDF]

open access: yes, 2022
Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive type of pancreatic cancer (PCa) with a low survival rate. microRNAs (miRs) are endogenous, non-coding RNAs that moderate numerous biological processes.
Uysal Onganer, P.   +20 more
core   +1 more source

Pancreatic resections for advanced M1-pancreatic carcinoma : the value of synchronous metastasectomy [PDF]

open access: yes, 2010
Background: For M1 pancreatic adenocarcinomas pancreatic resection is usually not indicated. However, in highly selected patients synchronous metastasectomy may be appropriate together with pancreatic resection when operative morbidity is low ...
Chromik, Ansgar Michael   +11 more
core   +1 more source

Significance of High-Mobility Group A Protein 2 Expression in Pancreatic Ductal Adenocarcinoma and Ampullary Adenocarcinoma

open access: yes, 2023
BACKGROUND/AIMS: Pancreatic and ampullary adenocarcinoma (AAC) are quite resistant to chemotherapy with high metastasis potential. Our study aimed to interpret high-mobility group A protein 2 (HMGA2) expression in benign and precursor pancreatic lesions ...
Demir, Lütfiye   +9 more
core   +1 more source

Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts. [PDF]

open access: yes, 2013
Copyright: 2013 Hermann et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source ...
Tunici, P   +51 more
core   +2 more sources

Home - About - Disclaimer - Privacy